直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Firm
  • Offices
  • Careers
Finnegan
  • Articles & Books
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • IP Health Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

Director Vidal Clarifies That the Compelling Merits Determination Is Not a Substitute for the Fintiv Analysis

March 6, 2023

By Trenton A. Ward; Safiya Aguilar

Edited by Amanda K. Murphy, Ph.D.

On February 27, 2023, Director Vidal issued a precedential decision in CommScope v. Dali Wireless[1] vacating and remanding the Board’s institution decision based on a finding of compelling merits under Fintiv. The precedential decision was issued sua sponte by the Director a mere 20 days after the PTAB panel decided to institute trial in the case, and no order granting Director review had previously been entered in the matter. In her decision, Director Vidal acknowledges that her June 2022 Fintiv Guidance Memo “could be read to allow for a compelling merits determination as a substitute for a Fintiv analysis,” but, as she explains in this decision, “that was not [her] intent.”[2]  The steps below outline the limited circumstances in which a PTAB panel is to engage in the compelling merits determination.

CommScope Steps for the Evaluation of the Compelling Merits Question

(1) Assess Fintiv factors 1-5 to determine if they favor a discretionary denial.

(2) Only when the Fintiv factors favor discretionary denial should the PTAB panel evaluate the compelling merits question.

(3) If the PTAB panel finds compelling merits exist, the decision must “provide reasoning sufficient to allow the parties to challenge that finding and sufficient to allow for review of that decision.”[3]

In view of stepwise approach outlined above, the Director further explained that when the Board determines that “Fintiv factors 1–5 do not favor discretionary denial, the Board shall decline to discretionarily deny under Fintiv without reaching the compelling merits analysis.”[4]

Applying these standards to the issue at hand, the Director found that the Board improperly reached a compelling merits determination because it did not first assess whether Fintiv factors 1–5 favored discretionary denial .[5] The Director also found that the Board’s rationale for finding compelling merits was insufficient because it “[m]erely point[ed] to its analysis under the lower institution standard,” reasonable likelihood, “without reference to the higher standard required for compelling merits.”[6] Specifically, Director Vidal instructs that a panel finding in favor of the compelling merits question must “provide reasoning sufficient to allow the parties to challenge that finding and sufficient to allow for review of the Board’s decision”[7] as articulated in the precedential decision OpenSky.[8]

Takeaway:

The compelling merits determination may now be seen as less impactful than many previously perceived.  Director Vidal clarifies that the compelling merits determination is not to serve as a substitute for the Fintiv analysis, but rather as a final consideration to be used after Fintiv factors 1-5 are determined to weigh in favor of a discretionary denial.  Further, a PTAB panel that finds compelling merits exist must provide reasoning to support and explain this determination, a requirement which may further discourage such findings by PTAB panels in the future.

Endnotes

[1] CommScope Technologies, LLC v. Dali Wireless Inc., IPR2022-01242, Paper No. 23 (PTAB Feb. 27, 2023).

[2] Id. at 4.

[3] Id. at 6.

[4] Id. at 4-5.

[5] Id. at 4.

[6] Id. at 5.

[7] Id. at 5.

[8] OpenSky Indus., LLC v. VLSI Tech. LLC, IPR2021-01064, Paper 107 (PTAB Oct. 14, 2022).

Tags

Patent Trial and Appeal Board (PTAB)

Related Practices

Enforcement and Litigation

Appeals

Patent Invalidation Proceedings

PTAB Post-Grant Review: IPR, PGR, and CBM

Related Offices

Atlanta, GA

London

Washington, DC

Contacts

Trenton_Ward
Trenton A. Ward
Partner
Atlanta, GA
+1 404 653 6441
Email
Safiya Aguilar
Associate
Washington, DC
+1 202 408 4160
Email
Amanda K. Murphy, Ph.D.
Partner
London
+44 (0)20 7864 2800
Email

Related Insights

Conference

21st Advanced Summit on Life Sciences Patents

May 18-19, 2023

New York

Conference

Auto IP USA 2023

May 4, 2023

Detroit

Conference

LESI Annual Conference

April 30, 2023 - May 2, 2023

Montreal

Workshop

Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology Patent Law

April 27, 2023

Cambridge

Webinar

No Laughing Matter: What the Intersection of Humor, the Lanham Act and the First Amendment Means for Brand Owners

April 25, 2023

Webinar

Seminar

Inadmissible Extension: Pitfalls in European and U.S. Proceedings

April 25, 2023

Munich

Conference

IAM Live: IP and Emerging Technology Europe 2023

April 19, 2023

London

Webinar

IP Due Diligence - Everything You Need To Know

March 30, 2023

Webinar

European IP Blog

The Implausibility of “Plausibility” as an Evidentiary Standard at the EPO

March 24, 2023

Due to international data regulations, we’ve recently updated our privacy policy. Click here to read our privacy policy in full.

We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.

The Finnegan UPC Hub is a one-stop shop for our insights related to the Unified Patent Court (UPC).

Finnegan
Click Here
  • Privacy
  • Disclaimer
  • EEO Statement

© 2023 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP